
# D15 — Deployment Readiness Assessment

## Executive Assessment

The frozen candidate has completed internal locked-test evaluation and D15
deployment/monitoring engineering design.

This does **not** establish production clinical deployment readiness.

## 1. Frozen Candidate

- Registry ID: DIABETES_READMISSION_XGB_D13_V1
- Model version: 1.0.0
- Candidate system SHA256: 9349A52C715517666540C0D5B1EDB148D48709C0FC2CC77BE9B53F10FE373679
- Operating threshold: 0.12

## 2. Internal Locked-Test Evidence

PR-AUC:

- Point estimate: 0.182040618234
- 95% bootstrap interval: [0.171914188149, 0.194827606210]

ROC-AUC:

- Point estimate: 0.623405163566
- 95% bootstrap interval: [0.609638638102, 0.638326603904]

Formal bootstrap replicates: 2000

These intervals characterize internal statistical uncertainty. They are not
production acceptance criteria.

## 3. Readiness Evidence Completed

- Frozen-system identity verification
- Controlled inference architecture
- Input and feature-contract design
- Monitoring-control catalogue
- Quantitative surveillance foundation
- Statistical uncertainty characterization
- Escalation framework
- Incident-management design
- Change-control design
- Rollback design
- Business-continuity design
- D14 residual-risk traceability

## 4. Material Unresolved Risks

Seven D14 residual risks remain unresolved:

1. Utilization-dependent model behavior
2. Explainability utilization dominance
3. Subgroup operating heterogeneity
4. Admission-context heterogeneity
5. Limited model discrimination
6. External transportability not established
7. Clinical effectiveness not established

## 5. Missing Deployment Evidence

The current evidence does not establish:

- external validation;
- prospective validation;
- real-world clinical effectiveness;
- live production monitoring performance;
- live incident-management implementation;
- live rollback implementation; or
- production clinical safety authorization.

## 6. Readiness Disposition

D15 engineering and governance design: **COMPLETED**

Research/validation prototype: **SUPPORTED**

Production deployment authorization: **NOT GRANTED**

External validation: **NOT ESTABLISHED**

Clinical effectiveness: **NOT ESTABLISHED**
